Reference 2 - Criteria for waiver of evidence of in vivo bioavailability or bioequivalence
FDA-2026-P-6541-0004Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Reference 2 - Criteria for waiver of evidence of in vivo bioavailability or bioequivalence
- Posted
- Jun 9, 2026
- Topics